American Healthcare REIT, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by American Healthcare REIT, Inc. (NYSE: AHR) on November 20, 2025, reporting events occurring on November 20 and November 24, 2025. The filing details the closing of a public offering of common stock and the execution of related forward sale agreements.
Key Financial Metrics and Capital Structure
The filing does not provide specific revenue, profit, cash flow, margin, or debt figures. The primary financial event reported is the capital raise through the sale of equity:
- Shares Sold: 8,100,000 shares of Common Stock ($0.01 par value).
- Offering Date: Closed on November 24, 2025.
- Underwriter: RBC Capital Markets, LLC.
- Over-Allotment Option: Underwriters were granted a 30-day option to purchase up to 1,215,000 additional shares.
- Proceeds Usage: Net proceeds are intended for general corporate purposes, including potential future investments.
Material Changes and Transaction Structure
The company executed a forward sale transaction structure:
- Forward Sale Agreement: Entered into on November 20, 2025, with a Forward Purchaser (an affiliate of the Underwriter).
- Hedging Mechanism: The Forward Seller borrowed and sold 8,100,000 shares on November 24, 2025, to hedge the Forward Purchaser's obligations.
- Settlement Terms: The company intends to deliver the 8,100,000 shares upon physical settlement on dates specified by the company, no later than May 20, 2027.
- Settlement Price: Cash proceeds per share will equal the public offering price less underwriting discounts and commissions, subject to adjustments.
- Contribution: Net proceeds from the settlement will be contributed to the Operating Partnership in exchange for limited partnership units.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance or management commentary on operational outlook. The primary risk disclosed relates to the settlement timeline and the nature of the forward sale agreement:
- Settlement Timing: Physical settlement is expected to occur on one or more dates no later than May 20, 2027.
- Settlement Method: The company retains the right to elect cash or net share settlement subject to certain conditions.
- Legal Disclaimer: The underwriting agreement representations and warranties are not representations of factual information to investors regarding the company's current condition.
Key Facts for Investor Verification
- Verify the final public offering price per share to calculate total gross proceeds.
- Confirm whether the underwriters exercised the option to purchase the additional 1,215,000 shares.
- Monitor the specific settlement dates selected by the company between the filing date and May 20, 2027.
- Review the definitive Underwriting Agreement (Exhibit 1.1) and Forward Confirmation (Exhibit 1.2) for specific adjustment formulas and conditions.
- Check subsequent filings for the actual contribution of proceeds to the Operating Partnership.